Intended for Healthcare Professionals

Conflow Bone Cements

See Product Sheet

Download PDF

Overview Benefits Education Additional Information Related Products

Reduced viscosity, with and without antibiotics, reliable performance and easy handling.

Conflow Bone Cements can perform as either medium or low viscosity, thereby offering an option for different needs and preferences.

With a reduced viscosity the cement will flow more easily which makes it ideal for syringe filling used in a lot of anatomical applications. In addition, the Conflow Bone Cements could be an option for larger joints arthroplasty when a low or medium viscosity alternative is preferred.

Procedures

Total and Partial Joint Replacements

Philosophies

Modern Cementing Technique

Application

Diverse Applications

Benefits

Reduced Viscosity – A Bone Cement with Easy Flow

Has reduced viscosity and can either perform as a medium or low viscosity bone cement depending on the time and temperature, thereby offering the flexibility to fit different needs and preferences. Ideal for syringe filling used in a range of anatomical applications.

Clinically Proven with Reliable Long-Term Results^1-8#

When used in total hip arthroplasty, 2, 5 and 10-year RSA data, collected on bone cement equivalent to Conflow Bone Cements, show satisfactory results with performance equivalent to the control group bone cement.^1-5 In addition, data from the Scandinavian registers (Norway and Sweden ) demonstrated survival rate in total hip and knee arthroplasty similar to other bone cements.^6-8

Antibiotic-loaded Option - Broad Antibacterial Spectrum

Conflow G Bone Cement includes gentamicin which has proven to be the antibiotic of choice for bone cement due to its broad antibacterial coverage.⁹
Conflow G Bone Cement includes 1g active gentamicin per 40g unit and provides high local concentrations of gentamicin over several days^.10*

Education

Literature

Conflow Bone Cement and Conflow G Bone Cement Product Sheet

Product sheet with key features and benefits

Conflow Bone Cement and Conflow G Bone Cement Mixing Chart

Conflow Bone Cement and Conflow G Bone Cement, non-prechilled, manual application

Additional Information

Söderlund, P. et al. 10 year results of a new low-monomer cement. Acta Ortopaedica. 83 (6):604-8, 2012.
Pitto, RP, et al. Cemex Genta bone cement in total hip arthroplasty. Clinical outcome and radiostereoanalysis of 25 hips with 2-year follow-up. South Auckland Clinical School, 2003.
Pitto, RP. Cemex System Genta bone cement in total hip arthroplasty: clinical outcome and radiostereoanalysis. A 5-year follow-up. South Auckland Clinical School, 2007.
Dahl, J., et al. Less wear with aluminium-oxide heads than cobalt- chrome heads with ultra-high molecular weight cemented polyethylene cups: a ten-year follow-up with radiostereometry. International Orthopaedics. 36 (3):485-90, 2012.
Nivbrant, B., et al. Bone cement with reduced proportion of monomer in total hip arthroplasty: pre-clinical evaluation and randomized study of 47 cases with 5 years’ follow-up. Acta Orthopaedica Scandinavica. 72 (6):572-84, 2001.
Norwegian Arthroplasty Register (NAR). Survival rate – Hip arthroplasy. Report 2017.
Norwegian Arthroplasty Register (NAR). Survival rate – Knee arthroplasy. Report 2017.
Swedish Hip Arthroplasty Register (SHAR ). Survival rate – Hip arthroplasy. Report 2018.
Kühn, K-D. Bone Cements, Up-to-Date Comparison of Physical and Chemical Properties of Commercial Materials. pp. 254-58. Springer Verlag: Berlin, 2000.
Data on file at TECRES S .P .A. Conflow and Conflow G Bone Cement Characterization and AB release.*
Malchau, H., et al. Prognosis of Total Hip Replacement. The National Hip Arthroplasty Register. 9-11, 1996.
Malchau, H., et al. The Swedish Total Hip Replacement Register. Journal of Bone and Joint Surgery. 84A: 2-20, 2002.
Swedish Hip Arthroplasty Register. Annual Report 1998.

*Laboratory testing is not necessarily indicative of clinical performance

#Data was collected on equivalent devices of the legal manufacturer

Refobacin^® is a trademark licensed from Merck KGaA.

TECRES S.P.A.
Via A. Doria, 6
37066 Sommacampagna
(VR) ITALY

Modern Cementing Technique (MCT) for long term implant survival.^11-13

The objective is to improve mechanical interlock and establish durable interfaces, both between implant-cement and cement-bone.

Learn More

Biomet Bone Cement R

High viscosity, non-antibiotic, radiopaque and easy handling.

Refobacin^® Bone Cement R

High viscosity, antibiotic-loaded, radiopaque and easy handling.

ClearMix^™ Vacuum Mixing System

The easy to use ClearMix System helps OR staff to produce high quality vacuum mixed cement

Compact Vacuum Cement Mixing Systems

The Compact System has been designed for fast, hassle-free mixing of high viscosity bone cement

Tailored resources for your patients.

Find videos, articles, and interactive content to guide your patients throughout their surgical journey on ReadyPatient.com, our dedicated patient recovery site.

Visit The ReadyPatient

All content herein is protected by copyright, trademarks and other intellectual property rights, as applicable, owned by or licensed to Zimmer Biomet or its affiliates unless otherwise indicated, and must not be redistributed, duplicated or disclosed, in whole or in part, without the express written consent of Zimmer Biomet.  

This material is intended for health care professionals. Distribution to any other recipient is prohibited.

For product information, including indications, contraindications, warnings, precautions, potential adverse effects and patient counseling information, see the package insert or contact your local representative; search this website for additional product information. To obtain a copy of the current Instructions for Use (IFU) for full prescribing and risk information, please visit labeling.zimmerbiomet.com or call 1-800-348-2759, press 4 for 411 Technical Support.